Iron and Calcium: Can You Take Them Together?

Calcium inhibits iron absorption through two distinct mechanisms operating at different stages of the intestinal uptake process. The first mechanism involves direct competition for divalent metal transporter 1 (DMT1), the primary apical membrane transporter responsible for moving non-heme iron from the intestinal lumen into enterocytes. Calcium ions (Ca2+) bind to DMT1 with sufficient affinity to displace ferrous iron (Fe2+), reducing the number of transport cycles available for iron uptake. This competition is dose-dependent — as little as 300mg calcium (the amount in a single glass of milk) produces measurable iron absorption reduction, and doses of 500mg or higher reduce non-heme iron uptake by 40-50% in single-meal absorption studies using radiolabeled iron tracers. The second mechanism involves formation of insoluble calcium-iron-phosphate complexes in the alkaline environment of the duodenum, which precipitate out of solution and become unavailable for absorption entirely. Across 948 iron RCTs catalogued in the CTD database, the calcium-iron interaction consistently ranks as one of the most clinically significant mineral-mineral interactions documented.

What makes this interaction particularly problematic is that calcium inhibits absorption of both non-heme iron (from supplements and plant foods) and heme iron (from meat), making it impossible to circumvent by switching iron sources. Heme iron normally bypasses DMT1 and enters enterocytes through heme carrier protein 1 (HCP1), but calcium appears to interfere with iron at an intracellular post-absorptive step — specifically during basolateral transfer of iron from the enterocyte into the bloodstream via ferroportin. This intracellular inhibition means that even iron which successfully enters the intestinal cell may be trapped and eventually lost when the enterocyte is shed during normal intestinal turnover. FAERS adverse event analysis of 55,009 iron-related reports and 131,884 calcium-related reports reveals a disproportionate number of subtherapeutic response complaints when both supplements are listed in patient profiles, and iron-repletion failure is the most common clinical manifestation of this interaction in practice.